{
  "doc_id": "Asherson_s-Syndrome",
  "doc_filename": "Asherson_s-Syndrome.pdf",
  "top_entities": [
    {
      "name": "wound",
      "mention_count": 2,
      "entity_type": "disease"
    },
    {
      "name": "autoimmune disorder",
      "mention_count": 1,
      "entity_type": "disease"
    }
  ],
  "file_size_bytes": 1911,
  "file_size_human": "1.9 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "CRM",
  "document_type_name": "Clinical Research Materials",
  "document_type_group": "Clinical Research Materials",
  "classification_confidence": 0.15,
  "title": "Asherson's Syndrome: Rare Autoimmune Disorder with Rapidly Progressive Blood Clots",
  "short_description": "Clinical overview of Asherson's syndrome, an extremely rare autoimmune disorder causing rapidly progressive blood clots affecting multiple organ systems.",
  "long_description": "This document provides a comprehensive clinical overview of Asherson's syndrome, an extremely rare autoimmune disorder first defined in medical literature in 1992. The condition is characterized by the rapid development of blood clots affecting multiple organ systems over hours, days, or weeks. The document discusses various triggers including infections, immunizations, physical trauma, and anticoagulation failures. With approximately 300 identified cases worldwide, the syndrome predominantly affects women and can occur at any age, though most cases are reported in young adults. This resource serves as an important reference for understanding the epidemiology, clinical presentation, and triggering factors of this rare but serious autoimmune condition.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T02:48:56.053434"
}